These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 14520120

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder.
    Sayyah M, Boostani H, Pakseresht S, Malaieri A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov 13; 33(8):1513-6. PubMed ID: 19737592
    [Abstract] [Full Text] [Related]

  • 25. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE.
    J Clin Psychiatry; 1990 Jul 13; 51(7):292-7. PubMed ID: 2195006
    [Abstract] [Full Text] [Related]

  • 26. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults.
    Greenberg WM, Benedict MM, Doerfer J, Perrin M, Panek L, Cleveland WL, Javitt DC.
    J Psychiatr Res; 2009 Mar 13; 43(6):664-70. PubMed ID: 19046587
    [Abstract] [Full Text] [Related]

  • 27. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.
    Diniz JB, Shavitt RG, Pereira CA, Hounie AG, Pimentel I, Koran LM, Dainesi SM, Miguel EC.
    J Psychopharmacol; 2010 Mar 13; 24(3):297-307. PubMed ID: 19164490
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S.
    Psychopharmacol Bull; 1990 Mar 13; 26(1):54-9. PubMed ID: 2196627
    [Abstract] [Full Text] [Related]

  • 30. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study.
    Kordon A, Wahl K, Koch N, Zurowski B, Anlauf M, Vielhaber K, Kahl KG, Broocks A, Voderholzer U, Hohagen F.
    J Clin Psychopharmacol; 2008 Oct 13; 28(5):550-4. PubMed ID: 18794652
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
    Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH.
    Biol Psychiatry; 2005 Sep 01; 58(5):424-8. PubMed ID: 15993857
    [Abstract] [Full Text] [Related]

  • 34. Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS.
    Khullar A, Chue P, Tibbo P.
    J Psychiatry Neurosci; 2001 Jan 01; 26(1):55-9. PubMed ID: 11212595
    [Abstract] [Full Text] [Related]

  • 35. Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine.
    Mundo E, Rouillon F, Figuera ML, Stigler M.
    Hum Psychopharmacol; 2001 Aug 01; 16(6):461-468. PubMed ID: 12404554
    [Abstract] [Full Text] [Related]

  • 36. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E, Mullen J, Brecher M, Paulsson B, Jones M.
    Curr Med Res Opin; 2005 Jun 01; 21(6):923-34. PubMed ID: 15969892
    [Abstract] [Full Text] [Related]

  • 37. Quetiapine addition in obsessive-compulsive disorder: is treatment outcome affected by type and dose of serotonin reuptake inhibitors?
    Denys D, Fineberg N, Carey PD, Stein DJ.
    Biol Psychiatry; 2007 Feb 01; 61(3):412-4. PubMed ID: 17241831
    [Abstract] [Full Text] [Related]

  • 38. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
    DeVeaugh-Geiss J, Landau P, Katz R.
    Psychopharmacol Bull; 1989 Feb 01; 25(1):36-40. PubMed ID: 2672070
    [Abstract] [Full Text] [Related]

  • 39. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases.
    Stamouli S, Lykouras L.
    J Clin Psychopharmacol; 2006 Aug 01; 26(4):396-400. PubMed ID: 16855458
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.